$TMP

Tompkins Financial Corp stock hits 52-week high at 76.38 USD

Tompkins Financial Corp (NYSE:TMP) stock reached a 52-week high of $76.38, reflecting a 9.52% increase over the past year and significant gains over six months (28.84%) and year-to-date (15.76%). The company's financial stability is supported by a 3.44% dividend yield and 52 consecutive years of dividend payments. Tompkins recently announced a 4.6% increase in its quarterly dividend and Piper Sandler initiated coverage with a Neutral rating, citing improved profitability after the sale of its insurance business.

Original reporting
Investing.com India · Investing.com
Published Dec 17, 2025, 3:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Dec 17, 2025, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$TMP
Bullish
high confidence
Mentioned
$TMP · $TMP
Relevance
6/10
AlphAI data visualization · based on Investing.com India
Decision brief

The 30-second read

$TMPBullishMed
01

Why it matters

The stock's 52-week high reflects investor confidence, possibly driven by improved profitability and dividend increases.

02

Market read

The stock's performance is relevant for investors focusing on regional banks and dividend-paying stocks.

03

What to watch

Potential macroeconomic headwinds or sector-specific risks could impact future performance.

Relevance 6/10Timing: Immediate to short-term

Background

Tompkins Financial Corp has a long history of dividend payments and recent positive earnings reports.

Company-level read

Ticker impact

$TMPBullishHigh confidence
Context

The stock has reached a 52-week high, indicating strong recent performance.

Expected impact

Moderate upward price movement expected in the short term.

Evidence & confidence

Consistent gains over the past year and recent dividend increase support continued positive momentum.

$TMPBullishMedium confidence
Context

The sentiment score indicates a bullish outlook, but with moderate confidence.

Expected impact

Potential for short-term gains, but not guaranteed.

Evidence & confidence

While recent performance is strong, external factors and market conditions could influence the stock.

Market effects

The financial sector may experience positive sentiment due to strong bank performance.

Limited regional impact; primarily affects local investors.

Minimal global relevance; specific to US financials.

Counterpoint

The stock may be overextended after recent gains; a short-term correction could occur.

Key entities

  • Tompkins Financial Corp

    A regional bank with a history of stable dividend payments.

  • Piper Sandler

    Initiated coverage with a Neutral rating, citing improved profitability.

Related articles

$TMPHigh

Tompkins Financial Corporation Reports Financial Results for Third Quarter of 2026

TOMPKINS FINANCIAL CORP (TMP) filed an SEC Form 8-K — Results of Operations and Financial Condition. For more information contact: Stephen S. Romaine, President & CEO Matthew Tomazin, Executive VP & CFO Tompkins Financial Corporation ( 888) 503-5753 For Immediate Release Friday, October 23, 2026 Tompkins Financial Corporation Reports Financial Results for Third Quarter of 2026 I

$TMPMed

Tompkins Financial Corporation (TMP) Q3 EPS $2.00, Up 21% YoY

Tompkins Financial Corporation reported Q3 2026 diluted EPS of $2.00, up 21% YoY and down 2% QoQ, with net interest margin at 3.65% and net interest income up 21% YoY to $77.3M. The company attributes these results to improving core banking metrics post-2025 divestiture, with NIM and loan growth driving EPS.

$TMPMed

Tompkins Financial Corporation Reports Record Financial Results for Third Consecutive Quarter

TOMPKINS FINANCIAL CORP (TMP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026pressrelease.htm EX-99.1 Document For more information contact: Stephen S. Romaine, President & CEO Matthew Tomazin, Executive VP & CFO Tompkins Financial Corporation ( 888) 503-5753 For Immediate Release Friday, July 24, 2026 Tompkins Financial Corporation Report

$BMYMed

Bristol Myers Squibb Reports CAR T-Cell Therapy Data In Multiple Sclerosis

Bristol Myers Squibb (BMY) reported interim Phase 1 Breakfree-2 study results for its CAR T-cell therapy zolacabtagene autoleucel in 66 multiple sclerosis patients. 92% of progressive MS patients showed stable or improved disability. Safety issues included cytokine release syndrome in 42.4% of patients. BMY stock is down 2.26% at $61.56.